GTCR, a leading private equity firm, announces it has signed a definitive agreement for Corza Medical, a leading global medical technology company, to sell its Biosurgery business unit, including the TachoSil® product portfolio, to EQT. Following the transaction, GTCR will retain ownership of Corza Medical and its Wound Closure, Ophthalmology and Biomedical Textiles business units. With a strong commitment to remarkable service, trusted performance, and outstanding economic value to customers, Corza Medical will continue to grow and invest across these businesses.
Read the full article: GTCR Announces Divestiture of Corza Medical’s Biosurgery Business Unit to EQT //
Source: https://www.prnewswire.com/news-releases/gtcr-announces-divestiture-of-corza-medicals-biosurgery-business-unit-to-eqt-302818940.html